Does taking antidepressants during pregnancy harm the child? Here are the facts


Ian Jones summarises a number of studies that consider the benefits and harms of antidepressants during pregnancy, including a recent cohort study that found that exposure to antidepressants in the womb is associated with a modest increased risk of speech and language disorders.

[read the full story...]

Time to stop prescribing antidepressants to young people with depression?


Andrew Shepherd considers the implications of a recent network meta-analysis of the efficacy and tolerability of antidepressants for children and adolescents with depression.

[read the full story...]

The side-effects of antipsychotics: let’s systematically assess, discuss and act! #NPNR2016


A live blog published at the 22nd International Network for Psychiatric Nursing Research conference in Nottingham.

Written by John Baker, Lucy Brazener, Wendy Cross, Vanessa Garrity, Andrew Grundy, Cher Hallett, Ben Hannigan, Elaine Hanzak and Alan Simpson.

[read the full story...]

Adding antidepressants to antipsychotics in schizophrenia: do they work, for what, and are they safe?


Alex Langford explores the emerging findings from a recent meta-analysis looking at the efficacy and safety of antidepressants added to antipsychotics for people with schizophrenia and schizophrenia-like psychosis.

[read the full story...]

Have the EAGLES landed? Safety of varenicline, bupropion and NRT in smokers with and without mental illnesses


Paul Christiansen presents the results of the EAGLES RCT into the neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patches in smokers with and without psychiatric disorders.

[read the full story...]

Acupuncture for mild cognitive impairment: rubbish in, rubbish out


Edzard Ernst shines a light on the unfounded claims presented in a meta-analysis published today on acupuncture for amnestic mild cognitive impairment.

[read the full story...]

ITI-007 for schizophrenia


Murtada Alsaif summarises a recent 4-week long phase II randomised controlled trial of ITI-007 for the treatment of schizophrenia, which contains some positive results for this novel intervention.

[read the full story...]

People’s experiences of taking antidepressants


Alison Faulkner reflects on the findings of a qualitative study from New Zealand that explores users’ diverse experiences of taking antidepressants.

[read the full story...]

Do prompts help sustain engagement with digital interventions?


Sarah Knowles considers the findings of a recent systematic review looking at the effectiveness of prompts to promote engagement with digital interventions.

[read the full story...]